PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through...
PMGC unit NorthStrive signs exclusive FSU license to develop multi-domain drone payload technology
PMGC rises 2% as unit plans EL-22 antigen study
PMGC slips 2% in regular trading after earlier 29% surge on research plan
PMGC (ELAB.US) surges 9% during regular trading
PMGC Surges 29% on Subsidiary FACS Research Plan
PMGC unit NorthStrive to launch independent FACS study to quantify EL-22 antigen expression